NovaBridge Biosciences (NBP) Cash from Financing Activities (2019 - 2025)
NovaBridge Biosciences (NBP) posted quarterly Cash from Financing Activities of -$3.0 million for Q4 2025, down 104.98% on a QoQ basis from $60.7 million in Q3 2025.
NovaBridge Biosciences (NBP) Cash from Financing Activities (2019 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has reported Cash from Financing Activities for 3 consecutive years, with -$3.0 million the latest figure, recorded in Q4 2025.
- Quarterly Cash from Financing Activities changed N/A year-over-year to -$3.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $57.7 million (down 85.85% YoY) and the FY2025 annual result came in at $57.7 million, up 17331.34% from the prior year.
- Cash from Financing Activities retreated to -$3.0 million in Q4 2025 per NBP's latest filing, from $60.7 million in the prior quarter.
- Over the last five years, Cash from Financing Activities for NBP reached as high as $60.7 million in Q3 2025 and fell as low as -$3.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 30.14 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 68.63 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 9,311.16 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -538.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -802.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 238.74 Mn |
| 10 | NovaBridge Biosciences | 389.86 Mn | 389.86 Mn | - | -3.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.02 Mn |
| Dec 31, 2025 | -3.02 Mn |
| Sep 30, 2025 | 60.75 Mn |
| Sep 30, 2025 | 60.75 Mn |
| Dec 31, 2020 | 127.47 Mn |
| Dec 31, 2020 | 127.47 Mn |
| Sep 30, 2020 | 280.56 Mn |
| Sep 30, 2020 | 280.56 Mn |
| Dec 31, 2019 | 16.07 Mn |
| Dec 31, 2019 | 16.07 Mn |